Abstract
Recently, it has been suggested that coxsackievirus plays an etiologic role in juvenile dermatomyositis (DM). Neutralizing antibodies to 12 coxsackievirus antigens were measured in the sera of four clinical subsets of patients with adult polymyositis (PM)/DM. Elevated antibody titers to coxsackievirus A7, B3, and B4 were detected in patients with adult PM, adult DM, and adult PM/DM with malignancy, respectively. The development of these three subsets of idiopathic inflammatory myopathies may be related to infection with specific coxsackievirus serotypes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Leff RL, Love LA, Miller FW, Greenberg SJ, Klein EA, Dalakas MC, Plotz PH (1992) Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle. Lancet 339:1192–1195
Chou SM, Gutmann L (1970) Picornavirus-like crystals in subacute polymyositis. Neurology 20:205–213
Tang TT, Sedmak GV, Siegesmund KA, McCreadie SR (1975) Chronic myopathy associated with coxsackievirus type A9. A combined electron microscopical and viral isolation study. N Engl J Med 292:608–611
Christensen ML, Pachman LM, Schneiderman R, Patel DC, Friedman JM (1986) Prevalence of coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 29:1365–1370
Bowles NE, Dubowitz V, Sewry CA, Archard LC (1987) Dermatomyositis, polymyositis and coxsackie-B-virus infection. Lancet I:1004–1007
Bohan A, Peter JB (1985) Polymyositis and dermatomyositis. N Engl J Med 292:344–347, 403–407
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
Arnett FC, Edworthy SM, Block DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH Luthra HS, Medsger TA Jr, Mitchell DM Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Nishikai M, Reichlin M (1980) Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum 23:881–888
Travers RL, Hughes GRV, Cambridge G, Sewell JR (1977) Coxsackie B neutralization titers in polymyositis/dermatomyositis. Lancet I:1268
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishikai, M. Coxsackievirus infection and the development of polymyositis/dermatomyositis. Rheumatol Int 14, 43–46 (1994). https://doi.org/10.1007/BF00300245
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00300245